Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
19 Mar 2025
// BIOSPACE
https://www.biospace.com/business/opko-and-entera-link-up-to-advance-first-oral-glp-1-glucagon-drug-into-clinic
08 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/08/2977864/0/en/Entera-Bio-Reports-Q3-2024-Financial-Results-and-Provides-Business-Updates.html
01 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/01/2922775/0/en/Entera-s-EB613-the-First-Once-Daily-PTH-1-34-Tablet-Treatment-Dedicated-to-Post-Menopausal-Women-with-High-Risk-Osteoporosis-Abstract-Selected-for-Presentation-at-the-ASBMR-2024-An.html
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2892199/0/en/Entera-Bio-Reports-Phase-1-Clinical-Data-of-First-in-Class-Oral-PTH-1-34-Peptide-Candidate-EB612-for-Patients-with-Hypoparathyroidism-at-ENDO-2024.html
20 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/20/2849325/0/en/Entera-Bio-Announces-Robust-Pharmacokinetic-Data-for-First-in-Class-Oral-GLP-2-Peptide-Tablet-Treatment-for-Patients-with-Short-Bowel-Syndrome.html
07 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/07/2683653/0/en/Entera-Bio-Adds-Sanofi-Commercial-Leader-Haya-Taitel-to-its-Board-of-Directors.html
ABOUT THIS PAGE